A

Abeona Therapeutics

D
ABEO
USD
0.09
(1.4308%)
Market Closed
8,526.00
Volume
-1.75
EPS
-
Div Yield
-3.604520
P/E
276,345,852.86
Market Cap
Today
1.4308%
1 Week
-0.313%
1 Month
-2.297%
6 Months
40.220%
12 Months
45.000%
Year To Date
27.345%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
S
SGMO
0.645
(29.9304%)
USD
C
CRSP
1.04
(2.0444%)
USD
E
EDIT
-0.11
(-3.3537%)
USD
N
NTLA
-0.05
(-0.3113%)
USD
V
VYGR
0.455
(6.8576%)
USD
REGN
REGN
8.505
(1.0417%)
USD
B
BLUE
-0.0615
(-14.0764%)
USD
ALNY
ALNY
-0.795
(-0.2913%)
USD
R
RGNX
1.77
(18.7898%)
USD
Q
QURE
0.26
(3.6212%)
USD

Title:
Abeona Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
Do you need help or have a question?
Contact Us